We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.155 | 3.43% | 4.675 | 4.35 | 5.00 | - | 25,623 | 16:35:16 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.52 | 9.1M |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 04/9/2020 11:53 | Time for seat belts, guys and gals? Results of trial due for publication sometime next week? ... Dependant on editorial whims | yet another final | |
| 04/9/2020 11:05 | Possibly. I imagine some decent buy volume into the close due to FOMO. COPD results due and hopefully next week which is what SNG is primarily here for, a massive market so should propel the share price higher still and further validate the treatment/delivery method. Could also help accelerate Covid trials/licensing assuming all is well and safe. I'm fully loaded and having sliced have more than I have ever had and if no RNS on Monday and a little drop I'll sell elsewhere to buy more here. Only a matter of time until we break 200p and decent COPD results should be the catalyst for that and further news. | tickboo |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
